Suchergebnisse - "Bateson, Anna"

PubPharm (25)

1

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid

enthalten in: PLOS global public health | 2023

von Timm, J. | Bateson, A. | Solanki, P. | +7

2

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis

enthalten in: The New England journal of medicine | 2022

von Conradie, F. | Bagdasaryan, T. | Borisov, S. | +43

CommentIn: N Engl J Med. 2022 Sep 1;387(9):842-843. - PMID 36053511

3

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Bateson, A. | Ortiz Canseco, J. | McHugh, T. | +24

4

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

enthalten in: The New England journal of medicine | 2020

von Conradie, F. | Diacon, A. | Ngubane, N. | +24

CommentIn: N Engl J Med. 2020 Mar 5;382(10):959-960. - PMID 32130819

5

Gender differences in tuberculosis treatment outcomes : a post hoc analysis of the REMoxTB study

enthalten in: BMC medicine | 2018

von Murphy, M. | Wills, G. | Murthy, S. | +85

6

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis

enthalten in: BMC medicine | 2018

von Murthy, S. | Chatterjee, F. | Crook, A. | +80

7

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

enthalten in: BMC medicine | 2017

von Phillips, P. | Mendel, C. | Nunn, A. | +5

8

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

enthalten in: BMC medicine | 2017

von Phillips, P. | Mendel, C. | Nunn, A. | +5

9

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

enthalten in: BMC medicine | 2017

von Phillips, P. | Mendel, C. | Nunn, A. | +5

10

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Aarnoutse, R. | Kibiki, G. | Reither, K. | +73